NSE: POLYMED · 30 October 2026
- Poly Medicure Ltd. shares traded down 0.85% today, moving from a previous close of ₹1,461.90 to open at ₹1,454.00 before touching an intraday high of ₹1,477.00 and a low of ₹1,432.60.
- Poly Medicure informed the exchange that a meeting of the Board of Directors is scheduled for November 5, 2026. The board will consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026. This notice sets the upcoming reporting timeline for investors.
- Trading volume was 0.79 times the 20-day average daily volume.
Why is Poly Medicure share price falling on 30 October 2026?
Poly Medicure Ltd. shares traded down 0.85% today, moving from a previous close of ₹1,461.90 to open at ₹1,454.00 before touching an intraday high of ₹1,477.00 and a low of ₹1,432.60.
While the broader Nifty benchmark rose 0.51% and the Nifty Pharma sector index advanced 1.55%, Poly Medicure lagged behind the sectoral momentum. Over the preceding 20 trading days, the stock has experienced a pullback of 13.40%, even as it maintains a slight 5-day return of 0.38%.
Company filings show no same-day operational announcements linking directly to today's share movement, though recent disclosures indicate that the company has scheduled a board meeting for November 5, 2026, to review unaudited financial results for the quarter and half-year ended September 30, 2026. Prior corporate updates have focused on routine investor meets rather than immediate price catalysts.
68,574 shares traded by 30 October 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 86,634 shares (0.79 times). The five-day average daily volume was 54,306 shares. Separately, the NSE report for 29 October 2026 showed 18,118 shares delivered, representing 50.21% of that day’s traded volume. The same report recorded 7,143 trades.
With no direct same-day catalyst announced, today's 0.85% decline appears to reflect routine stock-specific consolidation and underperformance relative to a rising Nifty Pharma sector. Trading volume remained subdued at 0.79x of the 20-day average, suggesting a lack of aggressive selling pressure despite the ongoing 20-day downward trend.
Latest Company Developments
Poly Medicure informed the exchange that a meeting of the Board of Directors is scheduled for November 5, 2026. The board will consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026. This notice sets the upcoming reporting timeline for investors.
It establishes the official disclosure date for the company's upcoming quarterly financial performance.
Poly Medicure submitted the scrutinizer's report and voting results for its 31st Annual General Meeting held on September 5, 2026. Shareholders successfully approved all resolutions, including the adoption of financial statements, a final dividend declaration, and the re-appointment of directors.
It confirms shareholder approval for corporate actions and governance matters for the financial year.
Poly Medicure Limited has informed the Exchange that Record date for the purpose of Dividend is 29-Aug-2026.
Investor Call Scheedule to be held on 20th August, 2026 is Cancelled.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 9.77% on 30 September 2026. This compares with 9.61% on 30 June 2026, a change of +0.16 percentage points.
The filing reported 23 MF/UTI holders.
What to Watch Next
- Upcoming unaudited financial results scheduled for review on November 5, 2026
- Delivery percentage trends relative to the 20-day average volume of 68,574 shares
- Performance divergence against the Nifty Pharma sector benchmark
- Execution of export orders and medical device business expansion strategies
Other Dated Coverage
More Poly Medicure news and dated analysis →
Frequently Asked Questions
What is the latest Poly Medicure company news?
Poly Medicure informed the exchange that a meeting of the Board of Directors is scheduled for November 5, 2026. The board will consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026. This notice sets the upcoming reporting timeline for investors.
How strong was Poly Medicure’s trading volume?
68,574 shares traded, 0.79 times the 20-day average daily volume. The price and volume data are dated 30 October 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.